NOVO B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Novo Nordisk is a producer of insulin for diabetes treatment. In addition to the specialist expertise in diabetes, the company produces drugs for hormone treatment as well as for hemophilia and bleeding disorders. The products are found on a global market and are sold under separate brands. Novo Nordisk was founded in 1923 and is headquartered in Bagsværd, Denmark.
Lue lisääLiikevaihto mrd.
EBIT-% (oik.)
EPS (oik.)
Osinko %
Osavuosikatsaus Q3'26
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
